Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte supplement used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Potassium replenishment in patients with significant potassium losses (e.g., due to diuretics, vomiting, diarrhea, or inadequate dietary intake). ## Adult Dosing * **Oral:** * **Prevention:** 10-20 mEq daily in 1-2 divided doses. * **Treatment:** 40-100 mEq daily in 2-4 divided doses. Maximum recommended daily intake is typically 200 mEq. Individual doses should not exceed 20 mEq. * **Intravenous (IV):** * **Treatment of Hypokalemia:** Typically administered at a concentration not exceeding 40 mEq/L. Rates of infusion vary based on severity of hypokalemia and patient's cardiac status. * Mild to moderate hypokalemia: Up to 10-20 mEq/hour. * Severe hypokalemia or cardiac arrhythmias: May require faster infusion rates (e.g., 20-40 mEq/hour) in a critical care setting with continuous cardiac monitoring. Maximum infusion rate is generally considered 40 mEq/hour, but higher rates may be used in life-threatening situations under close medical supervision. * **Maintenance:** Varies based on individual needs, typically 10-20 mEq per day. * **Maximum Concentration:** Avoid concentrations greater than 40 mEq/L for peripheral IV administration to reduce phlebitis. Higher concentrations may be administered centrally. ## Pediatric Dosing Dosing is weight-based and depends on the severity of hypokalemia and clinical indication. Dosing should be guided by local protocols or specialist consultation. * **Oral:** Typical maintenance range is 1-2 mEq/kg/day divided into doses. Treatment doses can range from 2-5 mEq/kg/day, not to exceed adult maximums. * **Intravenous (IV):** Dosing varies significantly. Typical daily maintenance is 1-3 mEq/kg/day. Treatment doses can range from 0.5-2 mEq/kg per dose, administered over several hours. Maximum infusion rate is generally 0.3-0.5 mEq/kg/hour (or 20 mEq/hour if per dose limit). ## Dose Adjustments * **Renal Impairment:** Use with extreme caution and may require dose reduction or discontinuation due to risk of hyperkalemia. Monitor potassium levels closely. ## Contraindications * Hyperkalemia. * Conditions that predispose to hyperkalemia (e.g., untreated Addison's disease, severe renal impairment, anuria, oliguria, certain types of burns). * Certain gastrointestinal obstructions or motility disorders (for solid oral dosage forms). ## Adverse Effects * **Gastrointestinal (Oral):** Nausea, vomiting, diarrhea, abdominal pain, gastrointestinal bleeding or perforation (especially with sustained-release formulations or rapid ingestion). * **Cardiovascular (IV):** Arrhythmias, cardiac arrest (with rapid infusion or hyperkalemia). * **General:** Hyperkalemia (muscle weakness, paralysis, paresthesia, ECG changes, cardiac arrest), phlebitis (IV). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors (e.g., lisinopril, enalapril) and Angiotensin II Receptor Blockers (ARBs) (e.g., losartan, valsartan):** Increased risk of hyperkalemia. * **Nonsteroidal Anti-inflammatory Drugs (NSAIDs) (e.g., ibuprofen, naproxen):** May reduce the effectiveness of diuretics and increase the risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase the risk of digoxin toxicity. Hypokalemia can increase the risk of digoxin toxicity. ## Monitoring * Serum potassium levels (frequently, especially with IV administration or dose changes). * Renal function (serum creatinine, BUN). * ECG, particularly with IV administration or if hyperkalemia is suspected. * Signs and symptoms of hypokalemia or hyperkalemia. ## Clinical Pearls * Oral potassium chloride should be taken with meals or a full glass of water to minimize gastrointestinal upset and risk of ulceration. * Sustained-release formulations may cause gastrointestinal irritation or obstruction; consider alternatives if patient has motility issues. * Rapid IV infusion or excessive doses can be fatal. Always use infusion pumps for IV administration and monitor patients closely. * Correcting severe hypokalemia (serum potassium < 2.5-3.0 mEq/L) may require IV potassium. * Consider the total daily potassium intake from all sources, including diet and other medications. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete details and to ensure patient safety. Dosing may vary based on individual patient factors and institutional protocols.